Pradžia › IgA glomerulonefritas › Kalifornija
IgA glomerulonefritas klinikiniai tyrimai Kalifornija
8 tyrimai dėl IgA glomerulonefritas ieško dalyvių vietose Kalifornija.
Miestai Kalifornija
Oficialus tyrimo tekstas (anglų kalba)
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Kidney & Hypertension Center - Apple Valley, Apple Valley
- Scripps Green Hospital, Carlsbad
- UCLA Health David Geffen School of Medicine, Los Angeles
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06935357A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Chula Vista
Renkami dalyviai2 fazė
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07541287Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Valley Childrens Hospital, Madera
Renkami dalyviai3 fazė
Amžius nuo 2 iki 18 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06994845Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Academic Medical Research Institute, Los Angeles
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06466135Study of Ravulizumab in Pediatric Participants With Primary IgAN
- Research Site, Palo Alto
Renkami dalyviai3 fazė
Amžius nuo 2 iki 18 · Visoms lytims · Atnaujinta 2026-07-30 · NCT07024563Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- UCLA Medical Center, Los Angeles
Renkami dalyviai2 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06797518Atacicept in Multiple Glomerular Diseases
- Vera Therapeutics, Brisbane
Renkami dalyviai2 fazė
Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-06-26 · NCT06983028Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cedars-Sinai Medical Center, Los Angeles
Renkami dalyviai2 fazė
Amžius nuo 1 iki 17 · Visoms lytims · Atnaujinta 2026-05-12 · NCT05003986Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.